David D. Yang1, Brandon A. Mahal2, Vinayak Muralidhar2, Michelle D. Nezolosky3, Marie E. Vastola3, Shelby A. Labe3, Ninjin Boldbaatar3, Martin T. King1,3, Neil E. Martin1,3, Peter F. Orio1,3, Clair J. Beard1,3, Karen E. Hoffman4, Quoc-Dien Trinh1,5, Daniel E. Spratt6, Felix Y. Feng7, Paul L. Nguyen1,3
1Harvard Medical School, Boston, MA, USA
2Harvard Radiation Oncology Program, Boston, MA, USA
3Department of Radiation Oncology, Brigham and Women's Hospital/Dana-Farber Cancer Institute, Boston, MA, USA
4Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
5Division of Urological Surgery, Brigham and Women’s Hospital, Boston, MA, USA
6Department of Radiation Oncology, University of Michigan, Ann Arbor, MI, USA.
7Departments of Radiation Oncology, Urology & Medicine and Helen Diller Family Comprehensive Cancer Center, University of California at San Francisco, San Francisco, CA, USA
